Inhibition of gastric motility in cat by acetylcholine and ganglion stimulant drugs.
D000109:Acetylcholine / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001337:Autonomic Agents / Q000494:pharmacology*; D001949:Bretylium Compounds / Q000494:pharmacology; D002415:Cats; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology
D001337:Autonomic Agents; D001949:Bretylium Compounds; D006584:Hexamethonium Compounds; D010879:Piperazines; D013565:Sympatholytics; D001285:Atropine; D012110:Reserpine; D007545:Isoproterenol; D000109:Acetylcholine; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine